Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 6, 1998, Pages 551-555

  Ahuja, V ^a   Dhar, A ^a   Bal, C ^a   Sharma, M P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CARBON 14; CLARITHROMYCIN; LANSOPRAZOLE; PEFLOXACIN; PROTON PUMP INHIBITOR; SECNIDAZOLE; UREA; UREASE;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DUODENUM ULCER; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PEFLOXACIN; PROTON PUMPS;

EID: 0031811111     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00338.x     Document Type: Article

References (19)

1. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
2. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 87: 1716-27.
3. Van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996; 1: 6-19.
4. Bell GD. Conference Report: Duodenal ulcer trials reported at the European Helicobacter pylori Study Group. Edinburgh 1995. Aliment Pharmacol Ther 1996; 10: 49-54.
5. Lind T, Veldhuyzen Van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials: the MACH 1 Study. Helicobacter 1996; 1: 138-44.
6. Sharma S, Prasad KN, Chamoli D, Ayyagiri A. Antimicrobial susceptibility pattern and biotyping of Helicobacter pylori isolates from patients with peptic ulcer diseases. Indian J Med Res 1995; 102: 261-6.
7. Barradell LB, Faulds D, McTavish D. Lansoprazole: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid related disorders. Drugs 1992; 44: 225-50.
8. Nakao M. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori. J Clin Gastroenterol 1995; 20(Suppl.): S32-7.
9. Unge P, Berstad A. Pooled analysis of anti Helicobacter pylori treatment regimens. Scand J Gastroenterol 1996; 31(Suppl. 220): 27-40.
10. Bazzoli F, Zagari RM, Fossi S, et al. Effect of omeprazole, clarithromycin and tinidazole on the eradication of Helicobacter pylori and healing of gastric ulcer. Gastroenterology 1996; 110: A60 (Abstract).
11. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-69.
12. Harris AW, Misiewicz JJ. Eradication of Helicobacter pylori. Ballieres Clin Gastronenterol 1995; 9: 583-613.
13. Gillis JC, Wiseman LR. Secnidazole, a review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs 1996; 51: 621-38.
14. Glupczynski Y. European multicentre study group on antibiotic susceptibility of Helicobacter pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 777-81.
15. Cayla R, Zerbib F, Talbi P, Megraud F, Lamouliatte H. Pre and post treatment clarithromycin resistance of H.P. Strains: a key factor of treatment failure. Gut 1995; 37(Suppl. 1): A217 (Abstract).
16. Jaup BH, Borrby A. Comparison of two low dose one week triple therapy regimes with and without metronidazole for cure of H. pylori infection. Aliment Pharmacol Ther 1996; 10: 275-7.
17. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-16.
18. De Bartolo M, Reitmayer R, Olson C, Edmonds A. Effect of smoking on H. pylori eradication and duodenal ulcer recurrence in patient receiving dual therapy with clarithromycin in combination with omeprazole. Gastroenterology 1995; 108(Suppl.): A79 (Abstract).
19. Zala G, St Schwery R, Meyenberger CH, et al. The negative influence of smoking on H. pylori eradication depends on the therapy regimen. Gastroenterology 1994; 106: A215 (Abstract).